Please login to the form below
Dragonfly signs Celgene as partner for NK cell platform
Extends presence in haemato-oncology and solid tumours
J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial
The majority of patients on Tremfya achieved at least a 90% improvement from PASI score
Lilly partners with AC Immune on tau drug for Alzheimer’s
Potential payments of $1.7bn to Swiss firm
Axovant drops last ‘legacy’ drug to focus on gene therapies
Decision comes after nelotanserin failed to meet efficacy target
AZ and CRUK launch Cambridge genomics centre
New centre adds to Cambridge's biotech cluster
BMS to test Vedanta’s bacterial therapy with Opdivo
Will be trialled in those with advanced or metastatic cancers
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
Invests in Genomics England alliance, plus clinical trials expansion
Biogen picks up another drug from wide-ranging Ionis alliance
Aims to follow success of Spinraza
CAR-Ts take centre stage as ASH18 comes to a close
Candidates from Allogene, Legend Biotech and Novartis were among the highlights
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Amgen’s BCMA drug on course to challenge CAR-Ts in myelomaBiTE will rival therapies from Bluebird, Celgene/Juno, J&J/Legend biotech
-
Grail to initiate largest ever UK cancer screening studyWill start testing on 50,000 people in early 2019
-
Regeneron’s early stage bispecific shows promiseBispecifics and antibody drug conjugates will challenge CAR-Ts
-
ASH18: CAR-T and drugs give new options for multiple myelomaSan Diego congress showcasing data in important haematology markets
-
Bayer axes 1,250 pharma jobs, with R&D taking the bruntPart of massive layoff of 12,000 people across conglomerate
-
Novartis to relocate UK headquarters to London’s White CityEmerging life sciences hub has already attracted Autolus
-
Vertex rises on data for cystic fibrosis triple therapyCompany will wait for further results before filing
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
-
Dr Fiona Marshall heads up MSD's new UK research facility She will be based in London and focus on early bioscience discovery
Latest research appointments
Featured jobs
-
Account Director
-
Competitive Salary Offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Systematic Reviewer - Oxford
-
Negotiable
-
Business Director
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
-
Account Manager / Account Director
-
Competative
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
- Principal Health Economist - North-West
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Associate Director
-
£75, 000-90, 000
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
Subscribe to our email news alerts
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
